止血生物标志物的可靠性受患者个体内时间依赖性变异影响
该前瞻性研究对15名健康对照和22例有静脉血栓栓塞症(VTE)病史的患者每月随访6个月,用组内相关系数(ICC)评估核小体、血浆游离DNA及常规止血标志物的可靠性。结果显示核小体和血浆游离DNA的可靠性低,健康对照ICC分别为0.538和0.091,患者组分别为0.213和0.161;常规止血标志物和血细胞可靠性从差到好(健康对照)或从差到可接受(患者组)。止血生物学参数在短期内自发变异,其临床价值目前未知。
要点
- 核小体和血浆游离DNA在健康对照及VTE患者中可靠性均低。
- 常规止血标志物和血细胞可靠性在健康对照从差到好,在患者组从差到可接受。
- 止血生物学参数在VTE患者甚至正常个体中短期内自发变异。
核心结论
- 本研究首次显示止血生物学参数在VTE患者中短期内自发变异,在正常个体中亦如此,这种个体内变异的临床价值目前未知。
研究设计与样本
- 为期3年的前瞻性研究,纳入15名健康对照和22例随机选取的有VTE病史的患者,每月随访共6个月,用组内相关系数(ICC)评估标志物可靠性。
主要发现
- 健康对照中核小体ICC为0.538(95%CI 0.334-0.764),血浆游离DNA ICC为0.091(95%CI -0.026-0.328)。
- 患者组中核小体ICC为0.213(95%CI 0.042-0.463),血浆游离DNA ICC为0.161(95%CI 0.008-0.398)。
- 常规止血标志物和血细胞的可靠性在健康志愿者中从差到好,在患者组中从差到可接受。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Essentials Nucleosomes and free DNA are two newly described biomarkers in venous thromboembolism (VTE). Reliability of nucleosomes, plasma free DNA and conventional hemostasis markers were studied. Hemostasis biological parameters vary over a short time-frame in VTE patients. Hemostasis biological parameters also vary over a short time-frame in healthy controls. SUMMARY: Background Previous studies have associated neutrophil-derived circulating nucleosomes and plasma free DNA with venous thromboembolism (VTE). However, there are few data concerning these two biomarkers and no studies have compared the reliability of nucleosomes and plasma free DNA against that of conventional hemostasis markers. Objectives We performed a 3-year prospective study of nucleosomes and plasma free DNA levels in comparison with conventional hemostatic biomarkers and blood cells. Patients/Methods Fifteen healthy controls and 22 randomly selected patients with a history of VTE were followed monthly for 6 months. The reliability of these markers was evaluated by the intraclass correlation coefficient (ICCs). Results and Conclusions In healthy controls and patients, we found a low reliability for nucleosomes and plasma free DNA, with ICCs at 0.538 (95% confidence interval [CI], 0.334-0.764) and 0.091 (95% CI, -0.026-0.328), respectively, in the healthy controls, and at 0.213 (95% CI, 0.042-0.463) and 0.161 (CI 95%, 0.008-0.398) in the patient group. For the conventional hemostasis biomarkers and for blood cells, reliability ranged from poor to good in the healthy volunteers and from poor to acceptable in the patient group. Our study shows for the first time that hemostasis biological parameters spontaneously vary over a short time-frame in VTE patients and, more surprisingly, in normal individuals. The clinical value of such intra-individual variations is currently unknown. This variability might mean reinterpreting diagnostic or prognostic models based on static evaluation of individuals. Studying the intrinsic value of individual patterns of markers' variability is warranted.
引用
- Bouvier S, Bastide S, Chouirfa S, et al. Reliability of hemostasis biomarkers is affected by time-dependent intra-patient variability. J Thromb Haemost. 2018. PMID: 29883046. doi:10.1111/jth.14198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。